West Pharmaceutical Services, Inc. (BMV:WST)

Mexico · Delayed Price · Currency is MXN

4,435.00

0.00 (0.00%)

At close: Sep 23, 2025

Revenue

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2015 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2015 - 2020
Proprietary Products Revenue	2.44B	2.33B	Log In	Log In	Log In	Upgrade
Contract-Manufactured Products Revenue	573.70M	558.70M	Log In	Log In	Log In	Upgrade
Revenue (Total)	3.02B	2.89B	Log In	Log In	Log In	Upgrade

EBIT

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2015 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2015 - 2020
Proprietary Products Operating Profit	629.80M	577.80M	Log In	Log In	Log In	Upgrade
Contract-Manufactured Products Operating Profit	69.80M	72.30M	Log In	Log In	Log In	Upgrade
Operating Income (Other)	-111.70M	-80.20M	Log In	Log In	Log In	Upgrade
Operating Income (Total)	587.90M	569.90M	Log In	Log In	Log In	Upgrade

Key Performance Indicators

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	2014 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2014 - 2019
Organic Net Sales Growth	-1.50%	Log In	Log In	Log In	Upgrade